Effect of Hormonal Contraceptive Use on HIV Progression in Female HIV Seroconverters in Rakai, Uganda

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2010 May 27

PMID 20502314

Citations 17

Authors

Chelsea B Polis

Maria J Wawer

Noah Kiwanuka

Oliver Laeyendecker

Joseph Kagaayi

Tom Lutalo

Fred Nalugoda

Godfrey Kigozi

David Serwadda

Ronald H Gray

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the association between hormonal contraceptive use and HIV progression.

Design: A retrospective analysis of 625 female HIV seroconverters from a Ugandan cohort study.

Methods: Multivariate Cox regression analyses incorporating time-varying hormonal contraceptive exposure were used to estimate the adjusted hazard ratios of death, and a composite outcome of AIDS or death, associated with hormonal contraceptive use. Sensitivity analyses included lagging hormonal contraceptive exposure, varying comparison groups, and separately assessing effects of oral and injectable contraceptives.

Results: A total of 27.5% of women reported ever using hormonal contraception. Of 625 women, 104 (16.6%) died and 291 (46.6%) progressed to AIDS or death during observation. Time-varying hormonal contraceptive use was not associated with an increased hazard of death as compared with nonuse of hormonal contraception (adjusted hazard ratio 0.76, 95% confidence interval 0.41-1.39, P = 0.37), and was associated with a significantly reduced hazard of progression to AIDS or death (adjusted hazard ratio 0.70, 95% confidence interval 0.50-0.97, P = 0.03). None of the sensitivity analyses suggested an adverse effect of hormonal contraception on HIV progression.

Conclusion: Hormonal contraceptive use was not associated with faster progression to death, and was associated with a reduced hazard of progression to the composite outcome of AIDS or death.

Citing Articles

Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries.

Wall K, Rida W, Haddad L, Kamali A, Karita E, Lakhi S Epidemiology. 2016; 28(2):224-232.

PMID: 27893488 PMC: 5287431. DOI: 10.1097/EDE.0000000000000590.

Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV.

Scarsi K, Darin K, Chappell C, Nitz S, Lamorde M Drug Saf. 2016; 39(11):1053-1072.

PMID: 27562873 PMC: 5048570. DOI: 10.1007/s40264-016-0452-7.

Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women.

Wall K, Kilembe W, Haddad L, Vwalika B, Lakhi S, Khu N J Acquir Immune Defic Syndr. 2015; 71(3):345-52.

PMID: 26379070 PMC: 4752415. DOI: 10.1097/QAI.0000000000000848.

Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.

Whiteman M, Jeng G, Samarina A, Akatova N, Martirosyan M, Kissin D Contraception. 2015; 93(1):17-24.

PMID: 26197261 PMC: 4688178. DOI: 10.1016/j.contraception.2015.07.003.

Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.

Castilho J, Jenkins C, Shepherd B, Bebawy S, Turner M, Sterling T J Womens Health (Larchmt). 2015; 24(6):481-8.

PMID: 25751720 PMC: 4490777. DOI: 10.1089/jwh.2014.5003.

References

Patterson B, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D . Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol. 1998; 153(2):481-90. PMC: 1852974. DOI: 10.1016/S0002-9440(10)65591-5. View

Sewankambo N, Gray R, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F . Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS. 2000; 14(15):2391-400. DOI: 10.1097/00002030-200010200-00021. View

Wawer M, Serwadda D, Gray R, Sewankambo N, Li C, Nalugoda F . Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS. 1997; 11(8):1023-30. DOI: 10.1097/00002030-199708000-00011. View

Lavreys L, Chohan V, Overbaugh J, Hassan W, McClelland R, Kreiss J . Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS. 2004; 18(16):2179-84. DOI: 10.1097/00002030-200411050-00010. View

Stringer E, Kaseba C, Levy J, Sinkala M, Goldenberg R, Chi B . A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007; 197(2):144.e1-8. PMC: 2730754. DOI: 10.1016/j.ajog.2007.03.031. View

Allen S, Stephenson R, Weiss H, Karita E, Priddy F, Fuller L . Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda. J Womens Health (Larchmt). 2007; 16(7):1017-27. DOI: 10.1089/jwh.2006.0151. View

. Mortality among HIV-1-infected women according to children's feeding modality: an individual patient data meta-analysis. J Acquir Immune Defic Syndr. 2005; 39(4):430-8. DOI: 10.1097/01.qai.0000148531.04706.c0. View

Reynolds H, Steiner M, Cates Jr W . Contraception's proved potential to fight HIV. Sex Transm Infect. 2005; 81(2):184-5. PMC: 1764682. DOI: 10.1136/sti.2004.012013. View

Hunt J, Miller L, Platt J . Hormonal regulation of uterine macrophages. Dev Immunol. 1998; 6(1-2):105-10. PMC: 2276012. DOI: 10.1155/1998/87527. View

10.

Taha T, Kumwenda N, Hoover D, Kafulafula G, Fiscus S, Nkhoma C . The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa. Bull World Health Organ. 2006; 84(7):546-54. PMC: 2627383. DOI: 10.2471/blt.05.027664. View

11.

Fisher L, Lin D . Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health. 1999; 20:145-57. DOI: 10.1146/annurev.publhealth.20.1.145. View

12.

Arrive E, Newell M, Ekouevi D, Chaix M, Thiebaut R, Masquelier B . Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007; 36(5):1009-21. DOI: 10.1093/ije/dym104. View

13.

Trunova N, Tsai L, Tung S, Schneider E, Harouse J, Gettie A . Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology. 2006; 352(1):169-77. DOI: 10.1016/j.virol.2006.04.004. View

14.

Stringer E, Levy J, Sinkala M, Chi B, Matongo I, Chintu N . HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS. 2009; 23(11):1377-82. PMC: 4217202. DOI: 10.1097/QAD.0b013e32832cbca8. View

15.

Lieve V, Shafer L, Mayanja B, Whitworth J, Grosskurth H . Effect of pregnancy on HIV disease progression and survival among women in rural Uganda. Trop Med Int Health. 2007; 12(8):920-8. DOI: 10.1111/j.1365-3156.2007.001873.x. View

16.

Prakash M, Kapembwa M, Gotch F, Patterson S . Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J Reprod Immunol. 2002; 54(1-2):117-31. DOI: 10.1016/s0165-0378(01)00125-5. View

17.

Wawer M, Gray R, Sewankambo N, Serwadda D, Paxton L, Berkley S . A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 1998; 12(10):1211-25. DOI: 10.1097/00002030-199810000-00014. View

18.

Sagar M, Lavreys L, Baeten J, Richardson B, Mandaliya K, Ndinya-Achola J . Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS. 2004; 18(4):615-9. DOI: 10.1097/00002030-200403050-00005. View

19.

Curtis K, Nanda K, Kapp N . Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS. 2010; 23 Suppl 1:S55-67. DOI: 10.1097/01.aids.0000363778.58203.b6. View

20.

Coutsoudis A, Coovadia H, Pillay K, Kuhn L . Are HIV-infected women who breastfeed at increased risk of mortality?. AIDS. 2001; 15(5):653-5. DOI: 10.1097/00002030-200103300-00019. View